Insiders · OMGA

Yan Moore

Chief Medical Officer at Omega Therapeutics, Inc. (OMGA) since January 2022

Yan Moore has filed 5 insider reports with the SEC since January 2022, as chief Medical Officer at Omega Therapeutics, Inc. (OMGA). The latest filing, on February 9, 2024, reports grant or award at Omega Therapeutics, Inc. (OMGA).

Filings
5
Companies
1
Bought on market
None
Sold on market
None

Companies where Yan Moore is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Omega Therapeutics, Inc. logo
OMGA
Omega Therapeutics, Inc.
Chief Medical Officersince January 2022Feb 9, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Yan Moore with

Other insiders at the same companies

Questions about Yan Moore

What is Yan Moore's role at Omega Therapeutics, Inc.?
Yan Moore reports to the SEC as chief Medical Officer at Omega Therapeutics, Inc. (OMGA), according to the latest filing on February 9, 2024.
Has Yan Moore bought or sold stock recently?
No open-market purchases or sales by Yan Moore are on file. The filings report grant or award.
How do I get alerts when Yan Moore files?
Follow Yan Moore on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Yan Moore (SEC CIK 0001901999). Totals count each trade once, skipping amendments whose original is on file, from Jan 6, 2022 on. View on SEC EDGAR · Get this as JSON